Diabetic Nephropathy
Conditions
Interventions
experimental group:Shenan Tongluo decoction
control group:Placebo
Sponsors
Changchun University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. At the same time, it meets the diagnostic criteria and syndrome differentiation criteria of Chinese medicine, and the diagnostic criteria of Western medicine for diabetic nephropathy; 2. aged 18 to 65 years old; 3. HbA1c<=7%, for patients with severe complications such as recurrent hypoglycemia, severe microvascular or macrovascular complications, or patients who cannot meet the standard requirements after adequate treatment, HbA1c<=8%; 4. Control blood pressure below 130/80mmHg; 5. The patient knows and voluntarily participates in the trial study and signs the consent form, and has good compliance.
Exclusion criteria
Exclusion criteria: 1. Serious heart, brain, kidney and other complications; 2. Unwilling to cooperate with others (refer to those who cannot cooperate with dietary control or fail to take medicine as prescribed and affect the curative effect) and mental patients; 3. Patients with acute metabolic disorders such as diabetic ketoacidosis or co-infected patients within the past 1 month; 4. Pregnant or lactating women and those who may be allergic to this drug.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 24h urine protein quantification; | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting blood glucose ; Postprandial blood glucose;Glycated hemoglobin;Triglycerides;Total cholesterol;High density lipoprotein ;Low-density lipoprotein ;Serum metabonomics test ;Hemodynamic testing; | — |
Countries
China
Contacts
Public ContactLiu Le
Changchun University of Chinese Medicine
Outcome results
None listed